{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:26:31Z","timestamp":1788823591510,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.pupt.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T22:10:28Z","timestamp":1306275028000},"page":"563-570","source":"Crossref","is-referenced-by-count":35,"title":["Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: A randomised controlled 6-week trial"],"prefix":"10.1016","volume":"24","author":[{"given":"Helgo","family":"Magnussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Watz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kirsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Wray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Samuelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2011.05.003_bib1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1183\/09031936.05.00139104","article-title":"COPD: current therapeutic interventions and future approaches","volume":"25","author":"Barnes","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2011.05.003_bib2","series-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009)","author":"Global Initiative for Chronic Obstructive Lung Disease","year":"2009"},{"key":"10.1016\/j.pupt.2011.05.003_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1183\/09031936.06.00025805","article-title":"Chronic obstructive pulmonary disease: current burden and future projections","volume":"27","author":"Lopez","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2011.05.003_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study","volume":"370","author":"Buist","year":"2007","journal-title":"Lancet"},{"issue":"2 Pt 1","key":"10.1016\/j.pupt.2011.05.003_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1164\/ajrccm.161.2.9901044","article-title":"Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study","volume":"161","author":"Scanlon","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.pupt.2011.05.003_bib6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1590\/S0100-879X2005001000009","article-title":"Role of matrix metalloproteinases in the development of airway inflammation and remodeling","volume":"38","author":"Lagente","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"6","key":"10.1016\/j.pupt.2011.05.003_bib7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1189\/jlb.0607338","article-title":"Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation","volume":"82","author":"Van Lint","year":"2007","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.pupt.2011.05.003_bib8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(04)17025-6","article-title":"Prospects for new drugs for chronic obstructive pulmonary disease","volume":"364","author":"Barnes","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pupt.2011.05.003_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.2005.051979","article-title":"Matrix metalloproteinases in destructive pulmonary pathology","volume":"61","author":"Elkington","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2011.05.003_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/thx.2005.042432","article-title":"Elevated MMP-12 protein levels in induced sputum from patients with COPD","volume":"61","author":"Demedts","year":"2006","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.pupt.2011.05.003_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/thx.2006.068353","article-title":"Effect of an MMP-9\/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs","volume":"62","author":"Churg","year":"2007","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.pupt.2011.05.003_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s000110300020","article-title":"The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?","volume":"52","author":"Belvisi","year":"2003","journal-title":"Inflamm Res"},{"issue":"3","key":"10.1016\/j.pupt.2011.05.003_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cardiores.2005.11.032","article-title":"The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors","volume":"69","author":"Peterson","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.pupt.2011.05.003_bib14","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/sj.bjc.6600310","article-title":"Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial","volume":"86","author":"Bramhall","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pupt.2011.05.003_bib15","unstructured":"Data on file, AstraZeneca; 2010."},{"key":"10.1016\/j.pupt.2011.05.003_bib16","unstructured":"Dahl R, Titlestadt I, Lindqvist A, Wielders P, Wray H, Wang M, Samuelsson V, et al. The effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in patients with moderate-to-severe COPD: a randomised controlled trial, in preparation."},{"key":"10.1016\/j.pupt.2011.05.003_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1465-9921-10-12","article-title":"The effect of tiotropium therapy on markers of elastin degradation in COPD","volume":"25","author":"Ma","year":"2009","journal-title":"Respir Res"},{"issue":"10","key":"10.1016\/j.pupt.2011.05.003_bib18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.pupt.2011.05.003_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.105.3.782","article-title":"Effects of positive expiratory pressure breathing during exercise in patients with COPD","volume":"105","author":"van der Schans","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2011.05.003_bib20","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.1998.16.6.2150","article-title":"Phase I trial of marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer","volume":"16","author":"Wojtowicz-Praga","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pupt.2011.05.003_bib21","first-page":"1101","article-title":"Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies","volume":"4","author":"Nemunaitis","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pupt.2011.05.003_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfg464","article-title":"The changing profile of acute interstitial nephritis","volume":"19","author":"Baker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pupt.2011.05.003_bib23","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","article-title":"Acute interstitial nephritis: clinical features and response to corticosteroid therapy","volume":"19","author":"Clarkson","year":"2004","journal-title":"Nephrol Dial Tranplant"},{"key":"10.1016\/j.pupt.2011.05.003_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","article-title":"Drug-induced acute interstitial nephritis","volume":"60","author":"Rossert","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.pupt.2011.05.003_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.pupt.2011.05.003_bib26","series-title":"Drug-induced interstitial nephritis. Drug hypersensitivity","author":"Keller","year":"2007"},{"issue":"6","key":"10.1016\/j.pupt.2011.05.003_bib27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1378\/chest.08-0455","article-title":"Biomarkers in COPD. Are we there yet?","volume":"133","author":"Sin","year":"2008","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.pupt.2011.05.003_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1513\/pats.200904-019DS","article-title":"Biomarkers in chronic obstructive pulmonary disease","volume":"6","author":"Sin","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pupt.2011.05.003_bib29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1164\/rccm.200404-543OC","article-title":"Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease","volume":"170","author":"Sin","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2011.05.003_bib30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.200709-1356OC","article-title":"The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease","volume":"177","author":"Sin","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2011.05.003_bib31","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1164\/ajrccm.154.5.8912738","article-title":"Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study","volume":"154","author":"Gottlieb","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2011.05.003_bib32","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1183\/09031936.96.09071482","article-title":"MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial","volume":"9","author":"Luisetti","year":"1996","journal-title":"Eur Respir J"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455391100109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455391100109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T04:03:09Z","timestamp":1560225789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109455391100109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S109455391100109X"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2011.05.003","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}